Abstract: The present invention relates to an e-commerce method capable of integrated ordering and integrated shipment to help a user residing abroad to use a domestic online shopping mall, the e-commerce method including displaying a plurality of online shopping malls on a user terminal, displaying an integrated order product list for a plurality of products selected by a user's input from at least one online shopping mall on the user terminal, receiving a purchase-on-behalf request event for a product of the integrated order product list from the user terminal, receiving first-shipment completion information from an administrator when the first shipment of the product purchased on behalf of the user to a predetermined shipment destination is completed, and displaying an integrated shipping method list including a plurality of shipping methods corresponding to the product for the second shipment of the product to a user shipment destination on the user terminal.

Abstract: The present invention relates to an e-commerce method capable of integrated ordering and integrated shipment to help a user residing abroad to use a domestic online shopping mall, the e-commerce method including displaying a plurality of online shopping malls on a user terminal, displaying an integrated order product list for a plurality of products selected by a user's input from at least one online shopping mall on the user terminal, receiving a purchase-on-behalf request event for a product of the integrated order product list from the user terminal, receiving first-shipment completion information from an administrator when the first shipment of the product purchased on behalf of the user to a predetermined shipment destination is completed, and displaying an integrated shipping method list including a plurality of shipping methods corresponding to the product for the second shipment of the product to a user shipment destination on the user terminal.

Abstract: Disclosed are a compound represented by Formula (1) below, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3,and Xi to X6 are the same as defined in claim 1.

Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.

Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.

Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.

Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.

Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3, and X1 to X6 are the same as defined in Claim 1.